Status:
COMPLETED
Left-Atrium-Appendage Occluder Register - GErmany
Lead Sponsor:
Stiftung Institut fuer Herzinfarktforschung
Conditions:
Atrial Fibrillation
Stroke
Eligibility:
All Genders
Brief Summary
* Evaluation of safety and effectiveness of implantable LAA occluder in clinical practice * Indication: For which reasons is the indication for implantation of LAA-Occluder put for patients with atria...
Detailed Description
LAARGE aims to show the care reality of patients whose left atrial appendage (LAA) is closed by an implantable medical device. In particular the following questions should be answered: * Indication: ...
Eligibility Criteria
Inclusion
- Intention to laa occluder
Exclusion
- Missing informed consent
Key Trial Info
Start Date :
July 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 27 2017
Estimated Enrollment :
643 Patients enrolled
Trial Details
Trial ID
NCT02230748
Start Date
July 1 2014
End Date
March 27 2017
Last Update
September 6 2018
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Klinikum Coburg
Coburg, Germany, 96450
2
Institut für Herzinfarkforschung Ludwigshafen
Ludwigshafen, Germany, 67063
3
Universitätsmedizin Mannheim
Mannheim, Germany, 68167
4
Isar Herzzentrum
München, Germany, 80331